Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early success during the beginning trials, with one dog "almost back to normal." ...

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH ...

Cancer remains a leading cause of death in canines, with 1 in 4 dogs in the U.S. expected to be diagnosed with cancer in their lifetime. 2 Lymphoma, one of the most common cancers in dogs ...

"The completion of our critical study for LAVERDIA®-CA1 marks a major milestone in bringing forward an innovative therapy for canine lymphoma", said Dylan Balsz, CEO of Anivive. "We are excited ...